NVAX is at this level a must buy. The stock have bottomed today first day that we see volume and a move. 18% are short in this stock see here https://finviz.com/quote.ashx?t=NVAX
Also we have catalyst p3 drug in early Q1
Easy 100 till 200% till FDA decision. When approved a lot of more.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.